David Bonnel

Quantitative mass spectrometry imaging of propranolol and olanzapine using tissue extinction calculation as normalization factor

Grégory Hamm, David Bonnel, Raphaël Legouffe et al. · Journal of Proteomics · 2012 · 196 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

MALDI Imaging of Formalin-Fixed Paraffin-Embedded Tissues: Application to Model Animals of Parkinson Disease for Biomarker Hunting

Jonathan Stauber, R. Lemaire, Julien Franck et al. · Journal of Proteome Research · 2008 · 166 citations

Life Sciences, Neurobiology, Neuroscience +17

Multivariate analyses for biomarkers hunting and validation through on-tissue bottom-up or in-source decay in MALDI-MSI: application to prostate cancer

David Bonnel, Rémi Longuespée, Julien Franck et al. · Analytical and Bioanalytical Chemistry · 2011 · 79 citations · Full text

Medicine, Biomedical Sciences, Oncology +12

MALDI imaging mass spectrometry in ovarian cancer for tracking, identifying, and validating biomarkers.

Mohamed El Ayed, David Bonnel, Rémi Longuespée et al. · PubMed · 2010 · 73 citations · Full text

Medicine, Gynecology, Oncology +17

Molecular Validation of PACE4 as a Target in Prostate Cancer

François D’Anjou, Sophie Routhier, Jean‐Pierre Perreault et al. · Translational Oncology · 2011 · 69 citations · Full text

Medicine, Molecular Biology, Oncology +17